The Arora Report

CUBIST PHARMACEUTICALS (CBST) ACQUISITION TARGET

April 5, 2011

Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player.

Cubist has received upgrades from several brokers. At present, cubist satisfies only three screens of the ZYX Change Method. We will issue an actionable signal in ZYX BUY CHANGE ALERTS when all six screens are meet.

CBST, TEVA

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

AGGRESSIVE STOCK DIP BUYING – IRAN DOWNPLAYS ISRAELI ATTACK – FED OFFICIAL TALKS RATE HIKE

April 19, 2024

NEW DATA POINT SHOWS INSATIABLE DEMAND FOR AI CHIPS BUT CHART SHOWS BROADENING TOP PATTERN

April 18, 2024

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.